This is a the United States news story, published by ScienceDaily, that relates primarily to COVID-19 news.
For more the United States news, you can click here:
more the United States newsFor more vaccine development news, you can click here:
more vaccine development newsFor more news from ScienceDaily, you can click here:
more news from ScienceDailyOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like this article about vaccine development, you might also like this article about
COVID vaccine. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest dreaded long COVID news, vaccine news, news about vaccine development, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
COVID shotScienceDaily
•74% Informative
Fewer than 1 in 4 people in the United States have received last year's updated COVID-19 vaccine, despite a death toll of more than 23,000 Americans this year .
Symptoms indicate a robust immune response that is likely to lessen the chances of infection.
An absence of side effects does not mean the vaccine is not working.
VR Score
79
Informative language
82
Neutral language
64
Article tone
formal
Language
English
Language complexity
56
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
medium-lived
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links